ESS vs PRME · P/E 31, rev $1.89B vs rev $3.0M
Essex Property Trust Inc (ESS) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. PRME currently screens at market cap $570.8M.
Not investment advice. Open the ESS and PRME stock pages for the full models.
Not investment advice.